CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Jan. 28, 2018	Jan. 29, 2017
Cash flows from operating activities:
Net income	$ 5,249	$ 2,039
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	10,358	10,315
Amortization of deferred financing costs	435	477
Share-based compensation expense	5,870	3,042
(Gains) losses on assets, net	(320)	125
Provision for doubtful accounts	(20)	1,586
Provision for deferred income taxes	(1,676)	26
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	30,858	19,181
Inventories	(2,237)	(4,932)
Income taxes	2,373	(6,777)
Prepaid expenses and other	(2,567)	2,157
Accounts payable	(31,205)	(30,199)
Accrued expenses	(23,183)	(27,240)
Other, net	(515)	(163)
Net cash used in operating activities	(6,580)	(30,363)
Cash flows from investing activities:
Capital expenditures	(8,109)	(4,120)
Proceeds from sale of property, plant and equipment	2,249	0
Net cash used in investing activities	(5,860)	(4,120)
Cash flows from financing activities:
(Deposit) refund of restricted cash	(44)	117
Proceeds from stock options exercised	1,040	1,019
Proceeds from Amended ABL facility	43,000	30,000
Payments on Amended ABL facility	(33,000)	(30,000)
Payments on term loan	0	(10,000)
Payments on note payable	(441)	(431)
Payments of financing costs	(275)	0
Payments related to tax withholding for share-based compensation	(4,610)	(2,389)
Purchases of treasury stock	(46,705)	(3,533)
Net cash used in financing activities	(41,035)	(15,217)
Effect of exchange rate changes on cash and cash equivalents	237	86
Net decrease in cash and cash equivalents	(53,238)	(49,614)
Cash and cash equivalents at beginning of period	65,658	65,403
Cash and cash equivalents at end of period	$ 12,420	$ 15,789